Status:
COMPLETED
Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects
Lead Sponsor:
SVS Institute of Dental Sciences
Conditions:
Periodontitis
Eligibility:
All Genders
20-45 years
Phase:
EARLY_PHASE1
Brief Summary
This study was a single-arm trial to obtain preliminary data on the efficacy of collagen membranes impregnated with recombinant human fibroblast growth factor (rhFGF-2) in the treatment of Miller's cl...
Detailed Description
Soft tissues can be regenerated to cover root exposure and a thin biotype can be converted into a thick biotype by using recombinant human growth factor technology. A recent review stated that growth ...
Eligibility Criteria
Inclusion
- systemically healthy subjects between 20-55 years presenting with Miller's class I or class II gingival recession\[
Exclusion
- 1\. Recessions associated with root demineralization/caries, deep cervical abrasion or pulpal pathology, 2. Patients with history of systemic conditions affecting periodontium and, 3. Smokers.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04361630
Start Date
May 1 2019
End Date
December 1 2019
Last Update
May 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SVS Institute of Dental Sciences, Mahabubnagar
Hyderabad, Andhra Pradesh, India, 509002